These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2803920)

  • 41. Plasma pharmacokinetics of adriamycin and antipyrine and its relation to the therapeutic and toxic effects.
    Preiss R; Matthias M; Sohr R; Brockmann B; Hüller H
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S79-88. PubMed ID: 3842695
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of taxol and doxorubicin administered alone and in combination by continuous 72-hour infusion.
    Berg SL; Cowan KH; Balis FM; Fisherman JS; Denicoff AM; Hillig M; Poplack DG; O'Shaughnessy JA
    J Natl Cancer Inst; 1994 Jan; 86(2):143-5. PubMed ID: 7903702
    [No Abstract]   [Full Text] [Related]  

  • 43. Sequence-dependent alteration of doxorubicin pharmacokinetics by paclitaxel in a phase I study of paclitaxel and doxorubicin in patients with metastatic breast cancer.
    Holmes FA; Madden T; Newman RA; Valero V; Theriault RL; Fraschini G; Walters RS; Booser DJ; Buzdar AU; Willey J; Hortobagyi GN
    J Clin Oncol; 1996 Oct; 14(10):2713-21. PubMed ID: 8874332
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Intra-arterial infusion chemotherapy with adriamycin for the treatment of locally advanced breast cancer--studies of serum and tissue concentrations of adriamycin].
    Takatsuka Y; Imamotoh H; Tsuchiyama M; Numata N; Kawahara T
    Gan To Kagaku Ryoho; 1982 May; 9(5):880-7. PubMed ID: 7184432
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Can we use a Bayesian method to build a pharmacokinetic population in two steps?].
    Cabelguenne D; Bleyzac N; Pivot C; Maire P
    Therapie; 2000; 55(2):277-82. PubMed ID: 10967700
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A limited sampling strategy to estimate individual pharmacokinetic parameters of methotrexate in children with acute lymphoblastic leukemia.
    Plard C; Bressolle F; Fakhoury M; Zhang D; Yacouben K; Rieutord A; Jacqz-Aigrain E
    Cancer Chemother Pharmacol; 2007 Sep; 60(4):609-20. PubMed ID: 17195068
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of doripenem in infected patients treated within and outside the intensive care unit.
    Bhalodi AA; Keel RA; Quintiliani R; Lodise TP; Nicolau DP; Kuti JL
    Ann Pharmacother; 2013 May; 47(5):617-27. PubMed ID: 23585647
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CPT-11: population pharmacokinetic model and estimation of pharmacokinetics using the Bayesian method in patients with lung cancer.
    Yamamoto N; Tamura T; Karato A; Uenaka K; Eguchi K; Shinkai T; Ohe Y; Oshita F; Arioka H; Nakashima H
    Jpn J Cancer Res; 1994 Sep; 85(9):972-7. PubMed ID: 7961128
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optimal sampling strategy development methodology using maximum a posteriori Bayesian estimation.
    van der Meer AF; Marcus MA; Touw DJ; Proost JH; Neef C
    Ther Drug Monit; 2011 Apr; 33(2):133-46. PubMed ID: 21383653
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Population pharmacokinetics of topotecan: intraindividual variability in total drug.
    Montazeri A; Boucaud M; Lokiec F; Pinguet F; Culine S; Déporte-Féty R; Albin N; Laguerre B; Goupil A; Bugat R; Canal P; Chatelut E
    Cancer Chemother Pharmacol; 2000; 46(5):375-81. PubMed ID: 11127941
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy.
    Carlsson KC; Hoem NO; Glauser T; Vinks AA
    Clin Ther; 2005 May; 27(5):618-26. PubMed ID: 15978311
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Limited sampling strategies using Bayesian estimation or multilinear regression for cyclosporin AUC(0-12) monitoring in cardiac transplant recipients over the first year post-transplantation.
    Monchaud C; Rousseau A; Leger F; David OJ; Debord J; Dantoine T; Marquet P
    Eur J Clin Pharmacol; 2003 Apr; 58(12):813-20. PubMed ID: 12698308
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclophosphamide, methotrexate, and fluorouracil with and without doxorubicin in the adjuvant treatment of resectable breast cancer with one to three positive axillary nodes.
    Moliterni A; Bonadonna G; Valagussa P; Ferrari L; Zambetti M
    J Clin Oncol; 1991 Jul; 9(7):1124-30. PubMed ID: 2045854
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bayesian estimation of cyclosporin exposure for routine therapeutic drug monitoring in kidney transplant patients.
    Bourgoin H; Paintaud G; Büchler M; Lebranchu Y; Autret-Leca E; Mentré F; Le Guellec C
    Br J Clin Pharmacol; 2005 Jan; 59(1):18-27. PubMed ID: 15606436
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Study of dose escalation and sequence switching of administration of the combination of docetaxel and doxorubicin in advanced breast cancer.
    Itoh K; Sasaki Y; Fujii H; Minami H; Ohtsu T; Wakita H; Igarashi T; Watanabe Y; Onozawa Y; Kashimura M; Ohashi Y
    Clin Cancer Res; 2000 Oct; 6(10):4082-90. PubMed ID: 11051260
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adaptive control methods for the dose individualisation of anticancer agents.
    Rousseau A; Marquet P; Debord J; Sabot C; Lachâtre G
    Clin Pharmacokinet; 2000 Apr; 38(4):315-53. PubMed ID: 10803455
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sequence effect of epirubicin and paclitaxel treatment on pharmacokinetics and toxicity.
    Venturini M; Lunardi G; Del Mastro L; Vannozzi MO; Tolino G; Numico G; Viale M; Pastrone I; Angiolini C; Bertelli G; Straneo M; Rosso R; Esposito M
    J Clin Oncol; 2000 May; 18(10):2116-25. PubMed ID: 10811677
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Population pharmacokinetics and pharmacodynamics for treatment optimization in clinical oncology.
    Zandvliet AS; Schellens JH; Beijnen JH; Huitema AD
    Clin Pharmacokinet; 2008; 47(8):487-513. PubMed ID: 18611060
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A systematic review of limited sampling strategies for platinum agents used in cancer chemotherapy.
    Loh GW; Ting LS; Ensom MH
    Clin Pharmacokinet; 2007; 46(6):471-94. PubMed ID: 17518507
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Population pharmacokinetics of doxorubicin, etoposide and ifosfamide in small cell lung cancer patients: results of a multicentre study.
    Freyer G; Tranchand B; Ligneau B; Ardiet C; Souquet PJ; Court-Fortune I; Riou R; Rebattu P; Boissel JP; Trillet-Lenoir V; Girard P
    Br J Clin Pharmacol; 2000 Oct; 50(4):315-24. PubMed ID: 11012554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.